Company Updates
MedAdvisor Limited Receives Commitments to Raise $5m in Oversubscribed Public Offer
Highlights: MedAdvisor to list on the ASX via Exalt Resources (ASX:ERD) Offer attracts strong support from domestic institutional investors and pharmacy industry participants MedAdvisor has established important partnerships with pharmaceutical companies GSK, UCB, AstraZeneca and Apotex, as well as private health insurer, BUPA One quarter of Australian pharmacies subscribe to the MedAdvisor cloud-based pharmacy platform […]
Australian Cities – Globally Competitive But Can They Stay There?
The recent appointment of Jamie Briggs as the Minister for Cities and the Built Environment sends a strong message that our Federal leaders finally recognise that our cities are an essential ingredient in driving Australia’s economic and social prosperity. Our cities are home to our most valuable capital – human capital. Almost 80% of the […]
Bulletproof Completes Acquisition of Infoplex
8th October 2015, ASX Announcement Acquisition Complete- SPP Update Acquisition of Blue Chip private cloud company Infoplex Pty Ltd completed Share Purchase Plan closes on 30 October 2015 Bulletproof Group Limited (ASX:BPF) is pleased to announce that the acquisition of Infoplex Pty Ltd as announced on 16 September 2015, has today been completed with the […]
Booktrack Announces New Content Deals
7th October 2015, DBW Booktrack (www.booktrack.com), the first company to enrich the eBook experience by adding movie-style soundtracks and ambient sound while you read, today announced content partnerships with Sourcebooks, RosettaBooks, the Nelson Literary Agency, Orca Book Publishers and Mighty Media Press. These deals were inked just in time for the Frankfurt Book Fair, where […]
Global Drug Giant Merck is Investing in Australian Biopharmaceutical Bionomics
8th October 2015, By Chris Pash, Business Insider Global drug giant Merck & Co has made a strategic investment in an Australia biopharmaceutical company Bionomics, which works on the discovery and development of treatment for cancer and diseases of the central nervous system. Merck, one of the largest pharmaceutical companies in the world, is buying […]
Pie Funds Management Makes the Deloitte Fast 50 for the Third Year in a Row
Pie Funds is a boutique investment manager with one philosophy: invest wisely, sleep easy. Pie has made the Deloitte Fast 50 once again with impressive revenue growth. The secret to Founder/CEO Mike Taylor’s success? Check out his 5 tips for successful investing ABOUT PIE FUNDS MANAGEMENT Pie Funds is a boutique fund manager based in […]
SUDA Allowed First USA Patent for SUD-003 and SUD-004
8th October 2015, ASX Announcement SUDA has been allowed its first patent in the USA for “Oral Spray Formulations and Methods for Administration of Sildenafil” for the treatment of SSRI-induced erectile dysfunction and pulmonary arterial hypertension SUDA Ltd (ASX:SUD), a leader in mucosal drug delivery, today announces that the US Patent and Trademark Office has […]
Appointment of Deputy Chairperson at Big Un Limited
8th October 2015, ASX Announcement Big Un Limited is pleased to announce the appointment of executive director, Sonia Thurston, as Deputy Chairperson of Directors of the Company. Ms Thurston will act as Chairperson of the Company’s Extraordinary General Meeting to be held on Monday, 12 October 2015, in the absence of Mr Andrew Corner, Chairperson […]
OncoSil strengthens management team
8th October 2015, ASX Announcement OncoSil Medical Limited (ASX:OSL) (OncoSil Medical, the Company) is pleased to announces details of two new key appointments to its senior management team in preparation for the commercialisation of the Company’s OncoSilTM localised radiation treatment for cancer. Mr David James appointed Global Head of Manufacturing Operations Mr David James has […]
Backed By Leading Investment Groups and Family Offices
